2 results
Approved WMORecruitment stopped
The hypothesis is that a switch from intravenous to oral antimicrobial therapy is non-inferior to standard intravenous therapy in patients with low-risk SAB. Therefore, the primary objective of the trial is to demonstrate, that oral switch therapy (…
Approved WMOWill not start
To analyze the difference in fT>MIC at the target site and infection rate for a single dose of 1 and 2g of cefazolin.